ALB
Albemarle Corporation
NYSE · Basic Materials · Chemicals - Specialty · US
$126.96
−3.93%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.9B | 5.1B | 5.4B | 9.6B | 7.3B |
| Cost of Revenue | 4.5B | 4.5B | 5.3B | 8.4B | 4.2B |
| Gross Profit | 1.4B | 671.6M | 60.2M | 1.2B | 3.1B |
| Operating Expenses | |||||
| R&D Expense | 37.7M | 51.4M | 86.7M | 85.7M | 72.0M |
| SG&A Expense | 541.5M | 526.4M | 609.5M | 874.2M | 512.1M |
| General & Admin Expense | 126.4M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 128.2M | — | — | — | — |
| Total Operating Expenses | 707.4M | 577.8M | 696.2M | 959.9M | 584.1M |
| Cost and Expenses | 5.2B | 5.0B | 6.0B | 9.4B | 4.8B |
| Operating Income (EBIT) | 704.2M | 93.8M | (636.0M) | 241.1M | 2.5B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 172.8M | 207.7M | 165.6M | 116.1M | 123.0M |
| Net Interest Income | (172.8M) | (207.7M) | (165.6M) | (116.1M) | (123.0M) |
| Other Non-Op Income/Expense | (431.3M) | (402.1M) | (412.4M) | 1.9B | 704.3M |
| Non-Operating Income (excl Interest) | 266.9M | 194.5M | 246.8M | (2.0B) | (827.2M) |
| EBT (Pre-Tax Income) | 272.9M | (308.3M) | (1.0B) | 2.1B | 3.2B |
| Income Tax Expense | 90.7M | 156.9M | 87.1M | 430.3M | 390.6M |
| Bottom Line | |||||
| Net Income | 224.2M | (510.6M) | (1.2B) | 1.6B | 2.7B |
| Earnings from Cont. Ops | 182.2M | (465.2M) | (1.1B) | 1.7B | 2.8B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 57.4M | (677.4M) | (1.3B) | 1.6B | 2.7B |
| Per Share | |||||
| Basic EPS | $0.48 | ($5.75) | ($11.20) | $13.41 | $22.97 |
| Diluted EPS | ($0.03) | ($5.75) | ($11.20) | $13.36 | $22.84 |
| Revenue Per Share | $50.08 | $43.69 | $45.76 | $81.98 | $62.50 |
| Shares | |||||
| Basic Shares Outstanding | 118.0M | 117.7M | 117.5M | 117.3M | 117.1M |
| Diluted Shares Outstanding | 136.2M | 117.7M | 117.5M | 117.8M | 117.8M |
| Profitability Metrics | |||||
| EBITDA | 1.2B | 559.9M | (291.8M) | 2.6B | 3.6B |
| D&A | 792.9M | 660.6M | 590.9M | 429.9M | 300.8M |
| EBIT | 437.4M | (100.7M) | (882.8M) | 2.2B | 3.3B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026